Technion mourns the passing of Shalom Zielony

 “Mr Zielony, your actions cannot be described simply; you are a true visionary. You have provided us with the tools for genuine development. You have given us the foundations for our community. Thank you for giving our campus a heart and our students homes close to that heart. We truly feel blessed.”

Ori Avi-No’am, former chair of the Graduate Students Organization. 

 

“My mission in life is to provide others with the tools to realize their dreams and goals.”
Shalom (Stanley) Zielony ז”ל 

Shalom (Stanley) Zielony

Born in Jerusalem in and educated in Haifa, Stanley Shalom Zielony served in the communications division of the Hagana during the War of Independence and in the Israel Defense Forces after the establishment of the State. 

He moved to North America, settling in Canada, where he became involved in the export of pulpwood to Europe. He demonstrated his ingenuity by developing a more efficient machine to debark wood prior to process, and also designed Ways to improve the loading of pulpwood on cargo ships for transatlantic journeys. His ability to improve machinery transformed into his aptitude to improve processes. In 1967 Zielony founded New York Publications Expediting Services (PES.) that distributes scientific literature Worldwide. This was the first US company to use air freight and mail to import and export scientific journals and books between Europe and the US, Zielony became a World leader in scientific literature distribution as P.E.S. became the major conduit for leading international scientific publishers.



Throughout his life Stanley Shalom Zielony committed himself to help strengthen Israel by buttressing its scientific and technological character. His generosity and modesty are legendary. In 2003, he received a Technion Honorary Doctorate in appreciation of his recognition of the Institute’s critical role in the development and wellbeing of Israel, and in profound gratitude for his outstanding support of the quality of life at Technion, transforming the face of campus, improving Student life and supporting academic programs.


The inauguration of the Stanley Shalom Zielony Student Union Building
   


Zielony’s remarkable dedication to priority projects at Technion included funding for faculty recruitment, research, and campus life. The Shalom Zielony Plaza, dedicated in 2002, transformed the Technion into a more beautiful and vibrant campus with attractive waterfalls, a scenic promenade and an expansive central lawn providing a vvonderful location for large gatherings and ceremonies. 

The quality of student life has been greatly enhanced and revitalized by the Stanley Shalom Zielony Student Union Building the Stanley Shalom Zielony Graduate Student village, and the strengthening of the Unit for Student Advancement. Loved across campus, March 18th 2009 was declared “Zielony Day” to express the gratitude of Technion students and faculty. 

Zielony’s wish was to be buried at the family plot in Haifa, near Technion. His funeral, attended by his daughter Tamara, close family, friends, Technion staff and students, was a poignant yet optimistic tribute, a celebration of a life that touched so many. A recurring theme was the nobility of a man who felt lucky to be able to help others, especially young people. “Whenever I thanked Shalom for his magnificent gifts, he would respond: ‘My mission in life is to provide others with the tools to realize their dreams and goals. I feel privileged to have the opportunity to give, and to ensure the education of the next generation in Israel,” said Technion President, Professor Peretz Lavie. 


“Mr. Zielony’s abundant generosity to the Technion and the Student Association has had a significant impact on the students here and will continue to do so for generations to come,” said Assaf Zinger, chairman of the Technion Students Association. “Sir Winston Churchill once said: ‘We make a living by what we get, but we make a life by what we give.’ Mr. Zielony’s gifts are a testament to a life well lived.”

Technology Transfer All the Way.

File:Rasagiline-3D-balls-B.png
A flagship example of T3 Technology Transfer: Rasagiline – a discovery by Prof. Moussa Youdim now marketed as a drug for Parkinsons disease  Azilect(TM) by Teva Pharmaceuticals, also demonstrates the powerful Technion process of technology transfer – from the lab. to the marketplace. Image: Wikicommons.

Recent global headlines have evidenced the ongoing miracle of Israel’s ability to translate new discoveries into patented innovations that become applicable on world markets. In the past two months, two flagship companies created through the dynamic activities of the T3 – the Technion office of Technology Transfer, passed the key milestone and significant hurdle in the process of effective technology transfer, with the reception of approval from the US Food and Drug Administration (FDA).

The company Mazor Robotics won FDA approval to apply its robotic surgical system to neurosurgery in July 2012. In the same month, the flagship company Corindus won FDA approval for its CorPath 200 System to be used in performing percutaneous coronary interventions (PCI). The technology is now approved in the United States to assist interventional cardiologists in performing PCI, a procedure to restore blood flow to blocked arteries in patients with coronary artery disease (CAD).

The mission of T3 – the technology transfer arm of the Technion, is to transform scientific discoveries and innovative technologies into real-life, applied solutions for the advancement of humanity, the State of Israel, and the Technion. By creating optimal alliances between scientists, industry and investors, T3 facilitates the smooth transfer of technologies to the commercial sector. This is accomplished through the licensing of intellectual property and the establishment of start-up companies. Occasionally, T3 also plays an active role as an entrepreneur by building teams, preparing business plans and providing the capital necessary to bring the technologies developed by Technion researchers to maturity.

The Technion – Israel Institute of Technology is Israel’s first university and home to three Nobel Laureates. The Technion is credited worldwide for its ability to generate start-ups, its remarkable ability to innovate and its powerful connections to industry. Known as “Israel’s MIT,” the Technion has made a significant impact across the range of applied science and technology including electronics, information technology, water management, nanotechnology, life sciences & chemistry, clean-tech, materials engineering and aerospace engineering.

During the past years, T3 has enjoyed a robust and marked increase both in the number of patent families originating from Technion research as well as in the number of commercialization successes. With 80-100 new patent filings every year, over 400 granted patents and over 900 pending patents, Technion now has approximately 400 patent families available for commercialization.

 

Technion Supercomputing & the Octopus

Image courtesy of SGI

An SGI computer which has been nicknamed the ‘Octopus’ and which is currently the largest civil server cluster in Israel has been installed at the Technion computer labs.

The computer will mainly serve researchers at the Minerva Center for Cognitive Processes and the Russell Berrie Nanotechnology Institute (RBNI) but researchers from a variety of fields that demand high performance computing will also have access.

The Technion purchased the computer with all available management tools including administrative, applicative and compilers. The SGI InfiniBand Cluster supercomputer is equipped with over 1260 cores has 96 gigabytes of memory for every node with the nodes connected through an infiniBand communication protocol developed by Israel’s Mellanox Technologies and has a storage system with a minimum of 60 terabytes.

Speaking at a ceremony to launch the ‘Octopus’ at the Technion computer labs, Technion Deputy Senior Vice President Professor Daniel Rittel said: “The Octopus places us on equal footing with the world’s leading academic institutions.” Dr. Joan Adler a researcher at the Faculty of Physics noted that researchers are already reporting that the code is running 11 times faster on the Octopus than previous systems.

New Life – The Healing Promise of Stem Cells

Diseases and conditions where stem cell treatment is promising or emerging. Source: Wikipedia

Since the late 1990s, the Technion has been at the forefront of stem-cell research. Stem cells are the master keys because they can be converted into many different kinds of cells, opening many different doors to potential cures and treatments. Beating heart tissue is one of the major stem cell achievements from the Technion.

Healing the Heart

Technion scientists showed this year that they can turn skin tissue from heart attack patients into fresh, beating heart cells in a first step towards a new therapy for the condition. The procedure may eventually help scores of people who survive heart attacks but are severely debilitated by damage to the organ.
By creating new heart cells from a patient’s own tissues, doctors avoid the risk of the cells being rejected by the immune system once they are transplanted.Though the cells were not considered safe enough to put back into patients, they appeared healthy in the laboratory and beat in time with other cells in animal models.
“We have shown that it’s possible to take skin cells from an elderly patient with advanced heart failure and end up with his own beating cells in a laboratory dish that are healthy and young – the equivalent to the stage his heart cells were in when he was just born,” Prof. Lior Gepstein told the British national paper The Guardian.

Pancreatic Tissue for Diabetes

Prof. Shulamit Levenberg of the Technion, who has spent many years trying to create replacement human organs by building them up on a “scaffold,” has created tissue from the insulin-producing islets of Langerhans in the pancreas surrounded by a three-dimensional network of blood vessels.The tissue she and her team created has significant advantages over traditional transplant material that has been harvested from healthy pancreatic tissue.

“We have shown that the three-dimensional environment and the engineered blood vessels support the islets – and this support is important for the survival of the islets and for their insulin secretion activity”, says Prof. Levenberg of the Department of Biomedical Engineering.

In the Bones

BonusBio - Health News - Israel


In collaboration with industry and global research partners, Technion scientists have grown human bone from stem cells in a laboratory. The development opens the way for patients to have broken bones repaired or even replaced with entire new ones grown outside the body from a patient’s own cells. The researchers started with stem cells taken from fat tissue. It took around a month to grow them into sections of fully-formed living human bone up to a couple of inches long. The success was reported by the UK national paper The Telegraph.

Stem Cell Proliferation

““These are our next generation of scientists and Nobel Laureates,” says Prof. Dror Seliktar, of the Department of Biomedical Engineering. “The future of the Technion relies on that.”

Seliktar and his research team at the Lokey Center for Biomaterials and Tissue Regeneration at Technion is working on a new material for the mass production of stem cells to make their commercial use viable on an industrial scale.

“In the biotechnology industries, there is an inherent need for expanding populations of stem cells for therapeutic purposes,” says Seliktar, who has published over 50 papers in the field, won over 14 awards and launched one of Israel’s promising biotech startups, Regentis Biomaterials.

Read more.

Prof. Joseph Itskovitz-Eldor of the Faculty of Medicine was on the international team that in 1998 first discovered the potential of stem cells to form any kind of tissue and pioneered stem-cell technology. The breakthrough garnered headlines around the world. He is the Director of the Technion Stem Cell Center.

A Robotic Review from Israel

Robotics is the branch of technology that deals with the design, construction, operation and application of robots and computer systems for their control, sensory feedback, and information processing. These technologies deal with automated machines that can take the place of humans, in hazardous or manufacturing processes, or simply just resemble humans. Many of today’s robots are inspired by nature contributing to the field of bio-inspired robotics.
Watch robots come to life with this New Year Hip Hop greeting from Technion to its friends and colleagues around the world.
The creation of machines that could operate autonomously dates back to classical times, but research into the functionality and potential uses of robots did not grow substantially until the 20th century. Throughout history, robotics has been often seen to mimic human behavior, and often manage tasks in a similar fashion. Today, robotics is a rapidly growing field, as we continue to research, design, and build new robots that serve various practical purposes, whether domestically, commercially, or in search and rescue.
In 2012, Reuters reported that Intel will be collaborating with Technion scientists in research that could yield devices that even mimic the human brain by 2014 or 2015.

Many of the robotic solutions emerging around the world today can save lives, such as the micro robot marketed by the company Mazor, founded out of innovations from the laboratory of Technion Prof. Moshe Shoham. Yet beyond the first frontier of research, robots also offer a great way to inspire the upcoming generation with an interest in technology and ingenuity. 


These future young engineers can be seen below receiving a class from RoboThespian™. As its name implies, RoboThespian is a dramatic actor robot complete with gestures, facial expressions and flirtatious eyes. This experimental live lesson was given in the framework of the project conducted by Prof. Igor Verner of the Technion’s Department of Education in Technology and Science and Dr. Takuya Hashimoto of Tokyo University of Science together with Alex Polishuk and Niv Krainer of MadaTech and Technion. RoboThespian™, produced by “Engineered Arts” of the UK, was bought two years ago by MadaTech for the robotics exhibition held there. 
Watch the video below to see some of the Technion’s other robots in action. Students and Faculty members from Mechanical Engineering, Electrical Engineering and Computer Science create these amazing robots in the Biorobotics and Biomechanics, Control and Robotic and Intelligent Systems laboratories.